Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2023-02, Vol.200 (4), p.524-527
Hauptverfasser:	Qualls, David, Imber, Brandon S., Okwali, Michelle, Hamlin, Paul A., Kumar, Anita, Lahoud, Oscar B., Matasar, Matthew J., Noy, Ariela, Owens, Colette, Zelenetz, Andrew D., North, Victoria S., Schöder, Heiko, Dogan, Ahmet, Salles, Gilles, Yahalom, Joachim, Falchi, Lorenzo
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Murine-Derived - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Combined Modality Therapy diffuse large B cell lymphoma Humans Lymphoma, Large B-Cell, Diffuse - drug therapy ocular adnexa orbit outcomes radiation Rituximab Rituximab - therapeutic use treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!